Rice Hall James & Associates’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Rice Hall James & Associates’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-86,185	Closed	-$3.98M	–	313
2016 Q3	$3.98M	Buy	86,185 +21,907	+34%	+$1.24M	0.21%	100
2016 Q2	$3.28M	Buy	64,278 +11,807	+23%	+$587K	0.19%	101
2016 Q1	$2.22M	Buy	52,471 +35,591	+211%	+$1.81M	0.13%	154
2015 Q4	$1.33M	Buy	+16,880	New	+$976K	0.08%	220

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Rice Hall James & Associates's ISEE Position: Q4 2016 in Review

Rice Hall James & Associates sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2016, closing a stake of 86,185 shares — an estimated $3.98M sold.

Rice Hall James & Associates first reported a position in ISEE in Q4 2015 and held it in 4 quarters. The position peaked at $3.98M in Q3 2016. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

Rice Hall James & Associates reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Rice Hall James & Associates sold 86,185 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $3.98M.
Rice Hall James & Associates first reported a position in IVERIC bio, Inc. Common Stock in Q4 2015 and held it in 4 quarters.
Rice Hall James & Associates's IVERIC bio, Inc. Common Stock position peaked at $3.98M in Q3 2016.
137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on Rice Hall James & Associates's 13F filing for Q4 2016, filed 2 Feb 2017.